Brief: AcelRx Pharma Says, On Nov 29, Co Got Notice From Patheon Pharma That It Intends To Terminate Manufacturing Services Agreement Between Parties - Filing

Talphera

05/12/2022 23:09

Dec 5 (Reuters) - AcelRx Pharmaceuticals Inc  ACRX.O :
    * ACELRX PHARMA- ON NOV 29, CO GOT NOTICE FROM PATHEON
PHARMA THAT
IT INTENDS TO TERMINATE MANUFACTURING SERVICES AGREEMENT BETWEEN
PARTIES
    * ACELRX PHARMACEUTICALS INC - BASED ON PATHEON’S DATE OF
NOTICE,
MSA WILL TERMINATE ON MAY 31, 2024
    * ACELRX PHARMACEUTICALS INC - PATHEON WILL CONTINUE TO
SUPPLY
PRODUCT UNDER MSA UNTIL TERMINATION DATE
    * ACELRX PHARMA- THE COMPANY EXPECTS TO DISCUSS A TRANSITION
PLAN
WITH PATHEON IN THE NEAR FUTURE

Further company coverage:  ACRX.O 
 ((Reuters.Briefs@thomsonreuters.com;;))